Filed: 2/14/2025ACC: 0001012975-25-000089
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $230.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$230.22M
Total AUM (reported)
40.23M
Total Shares
Allocation by class
COM$226.21M98.3%
COM NEW$3.44M1.5%
CLASS A COM$563.6K0.2%
Portfolio Concentration
Top 3$206.49M89.7%
4–10$23.72M10.3%
Top 3 weight
89.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 40.23M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
40.23M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings9
Rows:
BEAM THERAPEUTICS INC.
SOLEShares4.54M
TypeSH
Market value$112.60M
48.91%
Sole
0.00
Shared
0.00
None
4.54M
RAPPORT THERAPEUTICS, INC.
SOLEShares3.73M
TypeSH
Market value$66.15M
28.73%
Sole
0.00
Shared
0.00
None
3.73M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$27.75M
12.05%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$11.33M
4.92%
Sole
0.00
Shared
0.00
None
2.01M
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$7.29M
3.17%
Sole
0.00
Shared
0.00
None
8.06M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares126.63K
TypeSH
Market value$2.46M
1.07%
Sole
0.00
Shared
0.00
None
126.63K
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$1.10M
0.48%
Sole
0.00
Shared
0.00
None
320.48K
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$981.1K
0.43%
Sole
0.00
Shared
0.00
None
1M
CERO THERAPEUTICS HOLDINGS, INC.
SOLEShares9.39M
TypeSH
Market value$563.6K
0.24%
Sole
0.00
Shared
0.00
None
9.39M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INC.SOLE | COM | 4.54M | SH | $112.60M 48.91% | 0.00 | 0.00 | 4.54M |
RAPPORT THERAPEUTICS, INC.SOLE | COM | 3.73M | SH | $66.15M 28.73% | 0.00 | 0.00 | 3.73M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $27.75M 12.05% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $11.33M 4.92% | 0.00 | 0.00 | 2.01M |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $7.29M 3.17% | 0.00 | 0.00 | 8.06M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM NEW | 126.63K | SH | $2.46M 1.07% | 0.00 | 0.00 | 126.63K |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $1.10M 0.48% | 0.00 | 0.00 | 320.48K |
UNITY BIOTECHNOLOGY, INC.SOLE | COM NEW | 1M | SH | $981.1K 0.43% | 0.00 | 0.00 | 1M |
CERO THERAPEUTICS HOLDINGS, INC.SOLE | CLASS A COM | 9.39M | SH | $563.6K 0.24% | 0.00 | 0.00 | 9.39M |